Biotech stocks are surging. How investors can play the new drug innovation boom

Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.

Summary from the CNBC news feed. Copyright belongs to CNBC.

Read full story at CNBC ↗

Opens in a new tab, so Investz stays open.

ShareEmail X LinkedIn Facebook Reddit WhatsApp

More headlines

All news

MarketWatchEveryone’s talking about Roth conversions, but here’s how few people really do them — and why you shouldn’t have FOMO about it CNBCFire devastates former Nazi guest house 'Eagle's Nest' in Germany MarketWatchYoung Americans are giving up on car ownership. It’s a path to financial freedom for some.CNBCAn ex-bookkeeper spent $375 to launch a sewing business: 'I hadn't felt so sure about something like that in a long time'MarketWatchMy father-in-law, 81, sold his $75,000 home to pay his daughter’s $50,000 debt. How can I keep him from becoming destitute?MarketWatchInvestors’ recent money moves show a preference for lowering risks over boosting rewards

Headlines and summaries come from publishers’ public news feeds and are shown with attribution and a link to the original. Investz does not write or endorse them and they are not investment advice. Disclosures.